Our perspectives

in one place

News

See all
Statement 16 Jul 2024

Tenth meeting of the Intergovernmental Negotiating Body (INB)

On 16 July 2024, IFPMA delivered a statement at the tenth meeting of the Intergovernmental Negotiating Body (INB) in Geneva, Switzerland.

Read more
Press release 20 Jun 2024

Pharmaceutical industry welcomes the launch of Gavi’s new investment round and AVMA

On 20 June in Paris, Gavi, the Vaccine Alliance, the Government of France and the African Union – together with Team Europe partners, co-hosted The Global Forum for Vaccine Sovereignty and Innovation.

Read more
Press release 3 Jun 2024

Pharmaceutical industry response to pandemic preparedness agreements at World Health Assembly

On 1 June, member states represented at the World Health Assembly agreed on amendments to the International Health Regulations (2005), alongside the decision to complete negotiations on a pandemic agreement within a year. The pharmaceutical industry shared its response.

Read more
Statement 28 May 2024

WHA77 individual statement on the Working Group on Amendments to the International Health Regulations (2005)

On 28 May 2024, IFPMA submitted a statement at the World Health Assembly on Provisional Agenda Item 13.3, Working Group on Amendments to the International Health Regulations (2005). IFPMA acknowledges and appreciates the substantial efforts made by Member States in advancing the text of the Working Group on Amendments to the International Health Regulations (WGIHR)....

Read more
Statement 28 May 2024

WHA77 constituency statement on INB

On 28 May 2024, IFPMA, GSCF, GMTA, DVCMN, and BIO submitted a statement to the World Health Assembly on Provisional Agenda Item 13.4, Intergovernmental Negotiating Body to draft and negotiate a WHO convention, agreement or other international instrument on pandemic prevention, preparedness, and response.

Read more
Statement 27 May 2024

WHA77 constituency statement on NCDs and UHC

On 27 May 2024, IFPMA, IGBA, DITTA, GSCF, WHL, and PATH submitted a constituency statement to the World Health Assembly on Provisional Agenda Item 11.2, NCDs and UHC. IFPMA, IGBA, DITTA, GSCF, WHL, and PATH welcome the agenda item on non-communicable diseases (NCDs) and WHO’s continued commitment to this global health challenge. A life-course approach...

Read more

Join our media mailing list

If you're a journalist, please join our mailing list to receive regular press notifications.

    Top